Drug shortage: Flurazepam Hydrochloride Capsule (FLURAZEPAM HYDROCHLORIDE)
FDA lists 6 presentations as Current. Availability: Unavailable (2), Available (4). Reason: Regulatory delay. Companies: Chartwell Molecular Holdings LLC, Rising Pharma Holdings, Inc..
- Published by source
- 2022-08-03
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Chartwell Molecular Holdings LLC
- Products
- Flurazepam Hydrochloride Capsule FLURAZEPAM HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-08-03
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #985 | new | 2026-10-22 | 9ca0ccb6a3c1…9e73d3 | da83d94c6cca…42a259 |
Chain head: #1094 edf3be25ec2e…478842